Peptide Based Gastrointestinal Disorders Therapeutics Market

• 3.1. Teduglutide
• 3.2. Linaclotide

• 4.1. Hospital Pharmacies
• 4.2. Retail Pharmacies
• 4.3. Online Pharmacies

• 5.1. North America
• 5.2. Latin America
• 5.3. Europe
• 5.4. Japan
• 5.5. APEJ
• 5.6. MEA

• 12.1. Shire plc
• 12.2. Ironwood Pharmaceuticals, Inc
• 12.3. Astellas Pharma Inc
• 12.4. Allergan plc
• 12.5. Accredo Health Group, Inc

TABLE 01: Global Market Value (US$ Mn), 2012 to 2016

TABLE 02: Global Market Value (US$ Mn), 2017 to 2022

TABLE 3 :Global Market Value (US$ Mn) and Y-o-Y, 2015 to 2022

TABLE 04: Global Teduglutide Segment Value (US$ Mn), By Region 2012 to 2016

TABLE 05: Global Teduglutide Segment Value (US$ Mn), By Region 2017 to 2022

TABLE 06: Global Teduglutide Segment Market Share, By Region 2012 to 2016

TABLE 07: Global Teduglutide Segment Market Share, By Region 2017 to 2022

TABLE 08: Global Teduglutide Segment Y-o-Y, By Region 2015 to 2022

TABLE 09: Global Linaclotide Segment Value (US$ Mn), By Region 2012 to 2016

TABLE 10: Global Linaclotide Segment Value (US$ Mn), By Region 2017 to 2022

TABLE 11: Global Linaclotide Segment Market Share, By Region 2012 to 2016

TABLE 12: Global Linaclotide Segment Market Share, By Region 2017 to 2022

TABLE 13: Global Linaclotide Segment Y-o-Y, By Region 2015 to 2022

TABLE 14: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012 to 2016

TABLE 15: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2017 to 2022

TABLE 16: Global Hospital Pharmacies Segment Market Share, By Region 2012 to 2016

TABLE 17: Global Hospital Pharmacies Segment Market Share, By Region 2017 to 2022

TABLE 18: Global Hospital Pharmacies Segment Y-o-Y, By Region 2015 to 2022

TABLE 19: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012 to 2016

TABLE 20: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2017 to 2022

TABLE 21: Global Retail Pharmacies Segment Market Share, By Region 2012 to 2016

TABLE 22: Global Retail Pharmacies Segment Market Share, By Region 2017 to 2022

TABLE 23: Global Retail Pharmacies Segment Y-o-Y, By Region 2015 to 2022

TABLE 24: Global Online Pharmacies Segment Value (US$ Mn), By Region 2012 to 2016

TABLE 25: Global Online Pharmacies Segment Value (US$ Mn), By Region 2017 to 2022

TABLE 26: Global Online Pharmacies Segment Market Share, By Region 2012 to 2016

TABLE 27: Global Online Pharmacies Segment Market Share, By Region 2017 to 2022

TABLE 28: Global Online Pharmacies Segment Y-o-Y, By Region 2015 to 2022

TABLE 29: North America Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 30: North America Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 31: North America Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 32: North America Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 33: Latin America Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 34: Latin America Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 35: Latin America Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 36: Latin America Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 37: Europe Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 38: Europe Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 39: Europe Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 40: Europe Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 41: Japan Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 42: Japan Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 43: Japan Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 44: Japan Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 45: APEJ Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 46: APEJ Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 47: APEJ Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 48: APEJ Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 49: MEA Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 50: MEA Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 51: MEA Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 52: MEA Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 53: US Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 54: US Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 55: US Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 56: US Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 57: Canada Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 58: Canada Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 59: Canada Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 60: Canada Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 61: Brazil Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 62: Brazil Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 63: Brazil Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 64: Brazil Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 65: Mexico Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 66: Mexico Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 67: Mexico Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 68: Mexico Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 69: Argentina Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 70: Argentina Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 71: Argentina Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 72: Argentina Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 73: Germany Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 74: Germany Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 75: Germany Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 76: Germany Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 77: UK Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 78: UK Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 79: UK Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 80: UK Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 81: France Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 82: France Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 83: France Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 84: France Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 85: Spain Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 86: Spain Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 87: Spain Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 88: Spain Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 89: Italy Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 90: Italy Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 91: Italy Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 92: Italy Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 93: Nordic Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 94: Nordic Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 95: Nordic Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 96: Nordic Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 97: Japan Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 98: Japan Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 99: Japan Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 100: Japan Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 101: China Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 102: China Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 103: China Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 104: China Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 105: India Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 106: India Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 107: India Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 108: India Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 109: Malaysia Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 110: Malaysia Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 111: Malaysia Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 112: Malaysia Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 113: Thailand Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 114: Thailand Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 115: Thailand Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 116: Thailand Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 117: Singapore Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 118: Singapore Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 119: Singapore Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 120: Singapore Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 121: Australia Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 122: Australia Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 123: Australia Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 124: Australia Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 125: GCC Countries Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 126: GCC Countries Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 127: GCC Countries Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 128: GCC Countries Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 129: South Africa Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 130: South Africa Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 131: South Africa Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 132: South Africa Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 133: Nigeria Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 134: Nigeria Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 135: Nigeria Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 136: Nigeria Market Value (US$ Mn), By Distribution Channel 2017 to 2022

TABLE 137: Israel Market Value (US$ Mn), By Drug 2012 to 2016

TABLE 138: Israel Market Value (US$ Mn), By Drug 2017 to 2022

TABLE 139: Israel Market Value (US$ Mn), By Distribution Channel 2012 to 2016

TABLE 140: Israel Market Value (US$ Mn), By Distribution Channel 2017 to 2022

FIG. 01: Global Market Value (US$ Mn), 2012 to 2016

FIG. 02: Global Market Value (US$ Mn) Forecast, 2017 to 2022

FIG. 03: Global Market Value (US$ Mn) and Y-o-Y, 2015 to 2022

FIG. 04: Global Teduglutide Segment Market Value (US$ Mn) By Region, 2012 to 2016

FIG. 05: Global Teduglutide Segment Market Value (US$ Mn) By Region, 2017 to 2022

FIG. 06: Global Teduglutide Segment Y-o-Y Growth Rate, By Region, 2015 to 2022

FIG. 07: Global Linaclotide Segment Market Value (US$ Mn) By Region, 2012 to 2016

FIG. 08: Global Linaclotide Segment Market Value (US$ Mn) By Region, 2017 to 2022

FIG. 09: Global Linaclotide Segment Y-o-Y Growth Rate, By Region, 2015 to 2022

FIG. 10: Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012 to 2016

FIG. 11: Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2017 to 2022

FIG. 12: Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015 to 2022

FIG. 13: Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012 to 2016

FIG. 14: Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2017 to 2022

FIG. 15: Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015 to 2022

FIG. 16: Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012 to 2016

FIG. 17: Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2017 to 2022

FIG. 18: Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015 to 2022

FIG. 19: North America Market Value (US$ Mn), By Drug 2012 to 2016

FIG. 20: North America Market Value (US$ Mn), By Drug 2017 to 2022

FIG. 21: North America Market Value (US$ Mn), By Distribution Channel 2012 to 2016

FIG. 22: North America Market Value (US$ Mn), By Distribution Channel 2017 to 2022

FIG. 23: Latin America Market Value (US$ Mn), By Drug 2012 to 2016

FIG. 24: Latin America Market Value (US$ Mn), By Drug 2017 to 2022

FIG. 25: Latin America Market Value (US$ Mn), By Distribution Channel 2012 to 2016

FIG. 26: Latin America Market Value (US$ Mn), By Distribution Channel 2017 to 2022

FIG. 27: Europe Market Value (US$ Mn), By Drug 2012 to 2016

FIG. 28: Europe Market Value (US$ Mn), By Drug 2017 to 2022

FIG. 29: Europe Market Value (US$ Mn), By Distribution Channel 2012 to 2016

FIG. 30: Europe Market Value (US$ Mn), By Distribution Channel 2017 to 2022

FIG. 31: Japan Market Value (US$ Mn), By Drug 2012 to 2016

FIG. 32: Japan Market Value (US$ Mn), By Drug 2017 to 2022

FIG. 33: Japan Market Value (US$ Mn), By Distribution Channel 2012 to 2016

FIG. 34: Japan Market Value (US$ Mn), By Distribution Channel 2017 to 2022

FIG. 35: APEJ Market Value (US$ Mn), By Drug 2012 to 2016

FIG. 36: APEJ Market Value (US$ Mn), By Drug 2017 to 2022

FIG. 37: APEJ Market Value (US$ Mn), By Distribution Channel 2012 to 2016

FIG. 38: APEJ Market Value (US$ Mn), By Distribution Channel 2017 to 2022

FIG. 39: MEA Market Value (US$ Mn), By Drug 2012 to 2016

FIG. 40: MEA Market Value (US$ Mn), By Drug 2017 to 2022

FIG. 41: MEA Market Value (US$ Mn), By Distribution Channel 2012 to 2016

FIG. 42: MEA Market Value (US$ Mn), By Distribution Channel 2017 to 2022